FDA Replaces Regulations With Just Visit Our Website
Published Date: 6/15/2026
Rule
Summary
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FDA Centralizes Contact Info Online
If you interact with the FDA, information about the Agency's organization (including central and field offices) and relevant contact information, including email addresses, is available on the FDA website at http://www.fda.gov and in FDA's Staff Manual Guides. This change takes effect June 15, 2026 and directs the public to the Agency website as the uniform, updatable source of organizational and contact information.
No Added Costs or Paperwork Burden
FDA states this rule imposes no costs and contains no collection of information under the Paperwork Reduction Act; the rule lists 'Small Business: None' and declares no state/local/tribal impacts. The rule is effective June 15, 2026, so people and entities that contact FDA should not face new fees, paperwork, or delays because of this change.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-11993, Security Zone; Santa Monica Bay, Los Angeles, CA
The Coast Guard is setting up a temporary security zone in the waters near Los Angeles International Airport from June 15 to July 12, 2026, to keep everyone safe during the 2026 World Cup. Boats and people can’t enter this area unless they get special permission. This rule helps protect visitors and VIPs without causing delays or extra costs for most folks.
Next: 2026-12011, Miscellaneous Rules Relating to Common Carriers
This update fixes a technical error in the rules for common carriers, especially those handling video relay service (VRS) calls. VRS providers must now double-check who’s on the video side of each call using a special database, except for emergency 911 calls. These changes keep things running smoothly and make sure only eligible users get service—no extra costs or deadlines for you to worry about!